Text size decrease
The Evolution of SOMA (Carisoprodol)
SOMA® 250 mg builds on clinical experience with carisoprodol, a trusted medication in clinical use for nearly 50 years.
SOMA 250 mg: Relief Comparable to SOMA® 350 mg
In clinical trials, SOMA 250 mg demonstrated comparable efficacy to
SOMA 350 mg with better tolerability
- Powerful relief: Relief comparable to SOMA 350 mg
Acute Use
SOMA 250 mg is for short-term use up to 2 or 3 weeks, and is recommended for patients 16 years of age and older.
Reference
(1) SOMA [package insert]. Somerset, NJ: Meda Healthcare Inc.; 2007.
Request
Free Samples
Download a physician sample request form and fax it in to receive free SOMA 250 mg samples.
Instant Savings up to $30
Up To $30 OFF
Patients can save up to $30 toward SOMA 250 mg prescriptions through a simple, easy online form.
Important Information
SOMA (carisoprodol) is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. SOMA should be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration.
Since the effects of SOMA and CNS depressants (including alcohol) or psychotropic drugs may be additive, appropriate caution should be exercised with patients who take more than one of these agents simultaneously. In postmarketing experience with SOMA, cases of dependence, withdrawal, and abuse have been reported with prolonged use. SOMA should be used with caution in addiction-prone patients. There have been postmarketing reports of seizures in SOMA treated patients with most cases having occurred in the setting of multiple drug overdoses.
Most common side effects include drowsiness, dizziness and headache.
Please see full Prescribing Information.
SOMA® 250 mg is distributed by Meda Pharmaceuticals.
Contact Meda | Privacy Policy | Site Map
Copyright ©2008 Meda Pharmaceuticals Inc. All rights reserved.